Nerve monitoring during rectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial studies whether checking pelvic nerve signals during rectal cancer surgery (total mesorectal excision) is helpful. It may help surgeons avoid nerve injury while removing the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed rectal cancer from a biopsy
- You are scheduled for a complete rectal cancer surgery called total mesorectal excision (TME)
- You are under 90 years old
- You can sign the consent form and agree to the study
- This is not an emergency operation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of minimally invasive surgery for middle and low rectal cancer: robot-assisted (using a machine) and laparoscopic (using small incisions). The goal is to see which approach offers better outcomes for patients like you.
This trial tests whether using a special nerve monitor during prostate removal surgery helps preserve the nerves that control erections and bladder control, potentially reducing side effects. If you're scheduled for prostate cancer surgery, this could help improve your recovery.
This study uses special monitoring during surgery to watch the nerves that control bowel, bladder, and leg function. The goal is to help surgeons protect these nerves and predict your recovery after surgery.
This trial tests whether a small electrical device placed on the skin behind your ankle can help improve bowel control after surgery to remove rectal cancer. Many patients experience changes in bowel function after this surgery, and this treatment may help restore normal continence.
This trial tests whether starting a specific nerve stimulation treatment soon after rectal surgery can lower how often and how long a post-surgery bowel problem lasts. It may help patients recover with fewer symptoms after a low rectal anastomosis.
This trial tests whether removing lymph nodes in the pelvis during laparoscopic surgery for rectal neuroendocrine tumors (a type of slow-growing or aggressive tumor) improves outcomes. It is for people with larger or recurrent tumors, or those at higher risk due to tumor grade or depth.
Hear when a new Rectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.